Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
90 <strong>Annual</strong> Financial Statement Konzern-Jahresabschluss<br />
3.9. Financial risk management<br />
The group is open to various financial risks arising from its business and financial activities. Major risks<br />
arise from the financial standing and solvency of its partners as well as changes in interest rates.<br />
The financial risk management follows principles issued by the Executive Board. They include interest<br />
rate, market, credit, currency exchange and liquidity risks. Principles and guidelines also exist for other<br />
segments such as liquidity management as well as the acquisition of short-term and long-term loans.<br />
The financial risk management aims at hedging, if necessary, against the different risks mentioned<br />
above, thus limiting negative impacts on the income statement and the group’s balance sheet. By observing<br />
the principle of separation of functions, the financial risks to which the group is exposed are<br />
continuously evaluated, controlled and actively managed by various measures.<br />
Default Risk<br />
Business is only conducted with creditworthy partners after a credit assessment. Accounts receivable<br />
are constantly monitored and credit insurances concluded for selected customers. Significant risks cannot<br />
be observed. The non-payment risk for other financial assets is equal to their book value.<br />
Liquidity Risk<br />
The risk of a short-term liquidity shortage is observed by the management via liquidity monitoring.<br />
Therefore the maturity of financial assets, especially accounts receivable and accounts payable as well<br />
as the expected operating cash flow is constantly observed. The group is aiming at a balance between<br />
continuously covering the required financial resources and securing flexibility by use of financial investments<br />
and current account advances.<br />
Interest Risk<br />
The <strong>biolitec</strong> group minimizes interest rate risks from short-term interest rates changes by switching to<br />
medium-term orientated financing. The majority of the company’s debt is based on interest rates that<br />
are fixed for several years.<br />
If necessary, financial derivatives are introduced for the sake of risk minimization. In <strong>2009</strong>/<strong>2010</strong>, however,<br />
no such derivatives were used.